LogiPharma Europe: How Tech and Strategy is Shaping Modern Supply Chains

In the second part of his interview with Pharmaceutical Commerce, Anthony “TJ” Rizzo, chief commercial officer at Cold Chain Technologies, discusses how digital tools and strategic partnerships are reshaping modern pharma supply chains. Co-presenting with Johnson & Johnson at LogiPharma Europe 2026, Rizzo emphasizes that success is not defined by technology deployment alone, but by the outcomes those tools enable.

At the core of that shift is a more integrated approach between partners. For Rizzo, the greatest value comes when supply chain stakeholders align early, before a shipment moves, to co-design lanes, packaging strategies, and risk models. Real-time data is only as powerful as the decisions it informs. Trust, transparency, and shared accountability become essential, particularly as organizations work together to interpret data, manage exceptions, and continuously improve performance in a supply chain. Digital insight, he notes, must also be paired with human expertise to truly safeguard product integrity.

The conversation also explores how automation and real-time monitoring are fundamentally changing the way companies evaluate risk. Rather than relying on static, qualification-based assumptions, supply chains are becoming more dynamic and capable of modeling risk against real-world variability, such as shifting weather patterns or geopolitical disruptions. This evolution allows organizations to identify vulnerabilities earlier, pinpointing where lanes, regions, or handoffs are most likely to fail before issues escalate.

Watch the first part of Rizzo’s interview with PC:

1. LogiPharma 2026: How Automation Is Reshaping Pharma Supply Chains